PMID: 11917051Mar 28, 2002Paper

Randomized controlled crossover study of the effect on proteinuria and blood pressure of adding an angiotensin II receptor antagonist to an angiotensin converting enzyme inhibitor in normotensive patients with chronic renal disease and proteinuria

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Priscilla Kincaid-SmithDavid Packham

Abstract

Proteinuria and hypertension have independent deleterious effects on the progression of chronic renal disease. The objectives of this study were to determine whether the addition of Candesartan, an angiotensin II receptor antagonist, would reduce proteinuria and blood pressure in normotensive patients with chronic renal disease already receiving an angiotensin converting enzyme inhibitor (ACEI). This was an open randomized controlled crossover study conducted in a private consultant practice in Melbourne. Sixty patients, aged 23-75, who had chronic renal disease and stable proteinuria over 0.5 g in 24 h and were receiving an ACEI, were enrolled in the study. The patients were randomized to have 8 mg of Candesartan added in the first or second of two 12-week study periods. The primary end point was urine protein excretion, which was measured every 2 weeks for the 24-week period. Secondary end points included systolic and diastolic blood pressure, serum creatinine, urea and potassium levels. Candesartan was added against a background of standard care, which included other blood pressure lowering therapy. Lower urine protein excretion 2.4 vs 2.0 g in 24 h (P<0.04, difference 0.45, CI 0.01, 0.9) and lower levels of systolic blood p...Continue Reading

References

Jan 1, 1997·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·C ZoccaliA Zuccala'
Apr 23, 1999·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D RussoR Minutolo
May 3, 2000·Kidney International·M W Taal, B M Brenner
Jun 10, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·P RuggenentiG Remuzzi
May 31, 2001·Kidney International·R Agarwal
Jun 21, 2001·JAMA : the Journal of the American Medical Association·L Y AgodoaUNKNOWN African American Study of Kidney Disease and Hypertension (AASK) Study Group
Sep 22, 2001·The New England Journal of Medicine·E J LewisUNKNOWN Collaborative Study Group
Sep 22, 2001·The New England Journal of Medicine·B M BrennerUNKNOWN RENAAL Study Investigators
Sep 22, 2001·The New England Journal of Medicine·H H ParvingUNKNOWN Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group

❮ Previous
Next ❯

Citations

Nov 17, 2006·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Debbie S GipsonMarva Moxey-Mims
Aug 16, 2008·International Urology and Nephrology·Kostas C Siamopoulos, Rigas G Kalaitzidis
Sep 2, 2003·Current Hypertension Reports·Gozewÿn LavermanGiuseppe Remuzzi
Nov 6, 2004·Current Hypertension Reports·James P Smith, Julia B Lewis
Sep 3, 2004·Current Hypertension Reports·Niels H Andersen, Carl E Mogensen
Jul 15, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Priscilla Kincaid-SmithDavid Packham
Nov 12, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Marie Frimodt-MøllerAnne-Lise Kamper
Jan 29, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Vincent L M EsnaultOlivier Moranne
Jan 7, 2010·Current Opinion in Nephrology and Hypertension·Maartje C J SlagmanGozewijn D Laverman
Feb 19, 2005·Advances in Chronic Kidney Disease·S L WhiteS J Chadban
Jul 29, 2008·Renal Failure·J BasicV Milosevic
Sep 15, 2004·The Journal of Clinical Hypertension·Joseph L IzzoUNKNOWN AMAZE
Jan 30, 2004·Internal Medicine Journal·D W Johnson
May 12, 2009·Cardiovascular Therapeutics·N R RoblesJ J Cubero
Jan 18, 2008·Nephrology·Priscilla Kincaid-SmithJoseph Proietto
Aug 31, 2006·International Journal of Clinical Practice·N R RoblesE Sánchez Casado
Mar 31, 2009·European Journal of Internal Medicine·N R RoblesJ J Cubero
Aug 22, 2012·The American Journal of Medicine·Anil K BidaniMurray Epstein
Jun 27, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Martin MacKinnonHeather D Clark
May 17, 2006·Journal of Cardiovascular Pharmacology and Therapeutics·Sofia G TsouliMoses S Elisaf
May 13, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Fausta CatapanoGiuseppe Conte
Feb 14, 2006·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Peter Karl Jacobsen
Aug 6, 2004·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Trefor MorganRobert Jeffrey MacInnis
Apr 15, 2003·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Juliá SeguraLuis M Ruilope
Dec 24, 2004·Journal of the American Society of Nephrology : JASN·Vincent L M EsnaultJean-Michel Nguyen
Jun 19, 2014·The Cochrane Database of Systematic Reviews·Neil A SmartThomas Titus
Dec 10, 2003·Expert Opinion on Emerging Drugs·Prabal K Chatterjee, Christoph Thiemermann
Dec 19, 2003·Expert Opinion on Drug Safety·Ursula C Brewster, Mark A Perazella
Mar 31, 2021·The Cochrane Database of Systematic Reviews·Marguerite M ConleyHelen L MacLaughlin
Mar 28, 2003·Journal of the American Society of Nephrology : JASN·Peter JacobsenHans-Henrik Parving

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.